20m
Esperion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
FY25 Total Revenue Grew 21% Y/Y to $403.1 Million; FY25 U.S. Net Product Revenue Grew 38% Y/Y to $159.6 Million –– Q4 2025 U.S. Net Product ...
- FY25 Total Revenue Grew 21% Y/Y to $403.1 Million; FY25 U.S. Net Product Revenue Grew 38% Y/Y to $159.6 Million - - Q4 2025 U.S. Net Product Revenue Grew ~38% Y/Y to $43.7 Million; Q4 2025 Total ...
As cities across North America continue to deal with office space made surplus when remote work arrangements became mainstream during the pandemic, the concept of converting office buildings into ...
Envestnet, the Adaptive WealthTech company, today announces the rollout of its new proprietary Dash solution, available within Envestnet | MoneyGuide, designed to guide prospects and under advised ...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced ...
Early GO decision reached ahead of Q2'26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Key objectives achieved: ...
The Joint Entrance Examination (JEE) Main 2026 is one of the most competitive engineering entrance exams in India, conducted by the National Testing Agency (NTA) for admission to top engineering ...
Sport-related concussions are mild traumatic brain injuries that demand timely recognition and management. This review explores current evidence on pathophysiology, diagnosis, and treatment strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results